Jasper Therapeutics Inc.

NASDAQ: JSPR · Real-Time Price · USD
3.07
0.04 (1.32%)
At close: Aug 15, 2025, 3:59 PM
3.05
-0.65%
After-hours: Aug 15, 2025, 06:15 PM EDT

Jasper Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-108.59M -78.78M -71.27M -63.53M -62.44M -63.93M -64.47M -61.09M -55.41M -49.74M -37.69M -33.53M -25.08M -23.09M -30.64M -31.57M -28.17M -19.76M
Depreciation & Amortization
1.6M 1.36M 1.37M 1.41M 1.15M 1.12M 1.11M 1.1M 1.09M 1.03M 975K 896K 760K 571K 377K 183K 51K 22K
Stock-Based Compensation
9.41M 7.26M 6.62M 5.81M 5.2M 5.11M 5.21M 5.66M 4.91M 4.58M 4.09M 2.72M 2.27M 1.5M 1.05M 1.25M 1.06M 764.77K
Other Working Capital
2.58M -707K 295K -949K -223K 2.96M 2.72M 4.27M 3.44M -616K 1.5M -3.28M -1.81M -807K -1.32M 4.66M 1.56M 899.68K
Other Non-Cash Items
15.52M -258K 724K 1.5M 943K 505K 1.81M 751K 492K -565K -12.59M -15.46M -21.23M -19.77M -9.09M -2.04M 4.22M 4.14M
Deferred Income Tax
n/a n/a n/a -831K -831K -831K -831K n/a n/a n/a n/a -50K -500K -500K 3M 3.05M 3.5M 3.5M
Change in Working Capital
8.58M 707K -49K -2.3M 98K 556K 5.1M 5.36M 3.03M 2.71M -649K -2.37M -1.48M -405K 1.62M 4.63M 1.95M -261.32K
Operating Cash Flow
-73.48M -69.71M -62.6M -57.95M -55.88M -57.47M -52.07M -48.23M -45.9M -41.98M -45.86M -47.8M -45.26M -41.7M -33.68M -24.49M -17.39M -11.6M
Capital Expenditures
-377K -527K -552K -686K -412K -266K -267K -119K -341K -573K -576K -1.21M -1.45M -1.5M -2.43M -1.72M -1.25M -960K
Cash Acquisitions
8K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -138.24K n/a n/a n/a 138.24K
Other Investing Acitivies
206K 206K 202K 182K n/a n/a n/a n/a n/a n/a n/a n/a -218.24K n/a 138.24K 138.24K 356.48K 138.24K
Investing Cash Flow
-345K -503K -532K -686K -412K -266K -267K -119K -341K -573K -576K -1.21M -1.45M -1.5M -2.43M -1.72M -1.25M -960K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
538K 315K 315K n/a n/a -661 -661 27.34K 27.34K 28K 28K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
47.54M 47.54M 47.69M -145K -145K -450K -572K -245K -244K 74K 55K -882K 90.84M 90.23M 90.22M 91.18M -545K 55K
Financial Cash Flow
6.52M 535K 47.88M 47.27M 47.3M 46.81M 100.97M 101.27M 101.23M 101.55M 55K -882K 90.84M 90.23M 100.97M 112.68M 20.95M 21.55M
Net Cash Flow
-67.31M -69.68M -15.25M -11.37M -8.99M -10.93M 48.64M 52.92M 55M 59M -46.38M -49.88M 44.13M 47.04M 64.86M 86.48M 2.32M 9M
Free Cash Flow
-96.34M -70.23M -63.15M -58.63M -56.29M -57.73M -52.33M -48.35M -46.24M -42.55M -46.43M -49M -46.71M -43.19M -36.11M -26.2M -18.63M -12.56M